% | $
Quotes you view appear here for quick access.

Neurocrine Biosciences Inc. Message Board

  • frogsleapmerlot frogsleapmerlot Jul 20, 2011 9:35 AM Flag

    UC2 P2 results September/October

    UC2 alone if results are positive and NBIX managements is prudant in a partnership deal is worth 2 or 3 points to the current $8 stock price.

    If it gets to market let say in 2016/17 its a $1B/$2B drug.


    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • frogs

      This time you and I disagree.

      Assuming that you are correct and this is a multi billion dollar revenue producing drug, a partner is going to have to pay just as much to get this and maybe even more so I think your going to be a whole lot light on price if they get one of those $500 million deals with a bundle up front.

      Further this could easily happen at a time when Elagolix enters phaseIII with high expectations.

49.44-2.06(-4.00%)Aug 24 4:00 PMEDT